Older Drug for Advanced Breast Cancer Beat Newer, Pricier Meds

<p>MONDAY, Jun 4 (HealthDay News) Even in a margin of cancer
treatment, infrequently newer isnt indispensably better.
That might be a box for patients with advanced breast cancer, who
appeared to transport improved in a new investigate when they took an comparison drug, Taxol
(paclitaxel), instead of dual newer and some-more costly rivals.
Both of those newer medications, Abraxane and Ixempra, unsuccessful to
outperform Taxol in terms of possibly presence though course of
disease or a turn of a many noxious side effects, a investigate of almost
800 breast cancer patients found.
These information advise that identical patients might be reasonably treated
with weekly paclitaxel [Taxol], pronounced investigate author Dr. Hope Rugo, director
of breast oncology and clinical trials during a Helen Diller Family
Comprehensive Cancer Center during a University of California, San
Francisco.
She spoke during a news lecture Sunday during a American Society of Clinical
Oncology (ASCO) annual...